Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer (Q43835680)

27 November 2017

Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer. (English)

1 reference

27 November 2017

1 reference

C Aggarwal

1

1 reference

27 November 2017

N J Meropol

2

1 reference

27 November 2017

C J Punt

3

1 reference

27 November 2017

N Iannotti

4

1 reference

27 November 2017

B H Saidman

5

1 reference

27 November 2017

K D Sabbath

6

1 reference

27 November 2017

N Y Gabrail

7

1 reference

27 November 2017

J Picus

8

1 reference

27 November 2017

M A Morse

9

1 reference

27 November 2017

E Mitchell

10

1 reference

27 November 2017

M C Miller

11

1 reference

27 November 2017

S J Cohen

12

1 reference

27 November 2017

1 October 2012

1 reference

27 November 2017

1 reference

27 November 2017

24

1 reference

27 November 2017

2

1 reference

27 November 2017

420-428

1 reference

27 November 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

Specific carcinoembryonic antigens of the human digestive system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

Regression analysis of prognostic factors in colorectal cancer after curative resections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

Intensive follow-up after liver resection for colorectal liver metastases: results of combined serial tumour marker estimations and computed tomography of the chest and abdomen - a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

Cancer metastasis: building a framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

Detection of mutations in EGFR in circulating lung-cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

The CTC-chip: an exciting new tool to detect circulating tumor cells in lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS336

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDS336

1 reference

27 November 2017

1 reference